GORMAN KEVIN CHARLES Insider Trading Activity

Average Profitability
10.67%
Insider Buys Quantity
1
Insider Buys Sum
$1,013.36
Insider Sells Quantity
63
Insider Sells Sum
$132.28M

Insider Activity of GORMAN KEVIN CHARLES

According to the SEC Form 4 filings, GORMAN KEVIN CHARLES, being in a position of

  1. director at Neurocrine Biosciences, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 245088 shares for $37.82M,
    over all time since 2004-02-10, has bought 0 shares, and sold 2097511 share for $184.65M.

Biography of GORMAN KEVIN CHARLES

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $37,917,5302100

Comparison of Insiders on Amount of Buys and Sells

2026-06-15SaleXencor, Inc.
XNCR
director
7,527
0.0102%
$12.31$92,657+94.72%
2026-05-19SaleNeurocrine Biosciences, Inc.
NBIX
director
245,088
0.2437%
$154.33$37.82M+1.36%
2025-08-07SaleNeurocrine Biosciences, Inc.
NBIX
director
106,322
0.1079%
$126.41$13.44M+12.22%
2025-06-16SaleXencor, Inc.
XNCR
director
3,173
0.0045%
$9.22$29,255+32.93%
2025-05-27SaleNeurocrine Biosciences, Inc.
NBIX
director
9,613
0.0095%
$120.38$1.16M+10.35%
2025-02-13SaleNeurocrine Biosciences, Inc.
NBIX
director
5,844
0.0057%
$116.69$681,914+14.2%
2025-02-10SaleNeurocrine Biosciences, Inc.
NBIX
director
2,274
0.0022%
$118.37$269,167+12.24%
2025-01-31SaleNeurocrine Biosciences, Inc.
NBIX
director
2,707
0.0027%
$152.92$413,967-12.38%
2025-01-27SaleNeurocrine Biosciences, Inc.
NBIX
director
146,105
0.1447%
$149.46$21.84M-10.16%
2024-09-27SaleXencor, Inc.
XNCR
director
2,654
0.0038%
$20.68$54,885-44.54%
2024-02-13SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,832
0.0029%
$133.02$376,700+1.56%
2024-02-13PurchaseXencor, Inc.
XNCR
director
53
<0.0001%
$19.12$1,013+10.67%
2024-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,274
0.0022%
$134.15$305,052+1.15%
2024-02-06SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
3,040
0.0031%
$142.18$432,218-4.88%
2024-01-31SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,707
0.0027%
$140.69$380,845-2.7%
2024-01-09SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
62,023
0.0632%
$134.01$8.31M+1.3%
2024-01-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
105,835
0.1071%
$132.44$14.02M+1.13%
2023-08-21SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
9,328
0.0095%
$107.40$1M+23.68%
2023-02-08SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
2,274
0.0023%
$104.30$237,185+0.27%
2023-02-07SaleNeurocrine Biosciences, Inc.
NBIX
Chief Executive Officer
23,730
0.0241%
$102.42$2.43M+0.81%
Total: 69
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.